Significance of the imidazoline receptors in toxicology

References

• Waring J. Sedation as an unexpected systemic effect of privine. J Am Med Assoc 1945; 129:129.
   Web of Science ®Google Scholar
• Thomas J, Fabiano U. Privine sensitivity; a report of eight cases. South Med J 1946; 39:658–664.
   PubMedGoogle Scholar
• Hainsworth WC. Accidental poisoning with naphazoline (privine) hydrochloride. Am J Dis Child 1948; 75:76–80.
   PubMedGoogle Scholar
• House L, Carey W. Constitutional effects from the use of sympathomimetic drugs as nasal medication in children; report of case of privine toxicity. Laryngoscope 1948; 58:1294–1298.
   PubMed Web of Science ®Google Scholar
• Meeker C. Naphazoline hydrochloride poisoning in infancy. Northwest Med 1948; 47:743.
   PubMedGoogle Scholar
• Gillespie J. Poisoning from Naphazoline (Privine) hydrochloride. J Pediatr 1954; 44:443–444.
   PubMed Web of Science ®Google Scholar
• Friedman H. Reactions following use of nasal decongestants. J Am Med Assoc 1955; 157:1153.
   Google Scholar
• Greenstein N. Reactions following use of nasal decongestants. JAMA 1955; 157:1153.
   Google Scholar
• Brainerd WK, Olmsted RW. Toxicity due to the use of tyzine hydrochloride. J Pediatr 1956; 48:157–164.
   PubMed Web of Science ®Google Scholar
• Szabo B. Imidazoline antihypertensive drugs: a critical review on their mechanism of action. Pharmacol Ther 2002; 93:1–35.
   PubMed Web of Science ®Google Scholar
• Head GA. Imidazole receptors. 22-24 July 1998, Bonn, Germany. IDrugs 1998; 1:643–646.
   PubMedGoogle Scholar
• Chan CK, Burke SL, Head GA. Contribution of imidazoline receptors and alpha2-adrenoceptors in the rostral ventrolateral medulla to sympathetic baroreflex inhibition by systemic rilmenidine. J Hypertens 2007; 25:147–155.
   PubMed Web of Science ®Google Scholar
• Schmitt H, Schmitt H. Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan). Eur J Pharmacol 1969; 6:8–12.
   PubMed Web of Science ®Google Scholar
• Chan CK, Burke SL, Zhu H, Piletz JE, Head GA. Imidazoline receptors associated with noradrenergic terminals in the rostral ventrolateral medulla mediate the hypotensive responses of moxonidine but not clonidine. Neuroscience 2005; 132:991–1007.
   PubMed Web of Science ®Google Scholar
• Karppanen H, Paakkari I, Paakkari P. Further evidence for central histamine H2-receptor involvement in the hypotensive effect of clonidine in the rat. Eur J Pharmacol 1977; 42:299–302.
   PubMed Web of Science ®Google Scholar
• Ruffolo RR Jr, Rosing EL, Waddell JE. Receptor interactions of imidazolines. I. Affinity and efficacy for alpha adrenergic receptors in rat aorta. J Pharmacol Exp Ther 1979; 209:429–436.
   Google Scholar
• Bousquet P, Feldman J, Schwartz J. Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J Pharmacol Exp Ther 1984; 230:232–236.
   PubMed Web of Science ®Google Scholar
• Liu H, Du DM. Recent advances in the synthesis of 2-Imidazolines and their applications in homogenous catalysis. Adv Synth Catal 2009; 351:489–519.
   Web of Science ®Google Scholar
• Mahieu LM, Rooman RP, Goossens E. Imidazoline intoxication in children. Eur J Pediatr 1993; 152:944–946.
   PubMed Web of Science ®Google Scholar
• Tobias JD. Central nervous system depression following accidental ingestion of Visine eye drops. Clin Pediatr (Phila) 1996; 35: 539–540.
   PubMed Web of Science ®Google Scholar
• Lowry J, Rahman SA. Pediatric imidazoline poisonings as reported to U.S. poison control centers. North American Congress of Clinical Toxicology, Toronto September, 2008.
   Google Scholar
• Kappagoda C, Schell DN, Hanson RM, Hutchins P. Clonidine overdose in childhood: implications of increased prescribing. J Paediatr Child Health 1998; 34:508–512.
   PubMed Web of Science ®Google Scholar
• McGrath JC, Klein-Schwartz W. Epidemiology and toxicity of pediatric guanfacine exposures. Ann Pharmacother 2002; 36:1698–1703.
   PubMed Web of Science ®Google Scholar
• Head GA, Mayorov DN. Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc Hematol Agents Med Chem 2006; 4:17–32.
   PubMedGoogle Scholar
• Seger DL. Clonidine toxicity revisited. J Toxicol Clin Toxicol 2002; 40:145–155.
   PubMed Web of Science ®Google Scholar
• Bousquet P, Feldman J. Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection. Drugs 1999; 58: 799–812.
   PubMed Web of Science ®Google Scholar
• Bousquet P. Identification and characterization of I1 imidazoline receptors: their role in blood pressure regulation. Am J Hypertens 2000; 13:84S–88S.
   Google Scholar
• Morgan NG. Imidazoline receptors: new targets for antihyperglycaemic drugs. Expert Opin Investig Drugs 1999; 8:575–584.
   PubMedGoogle Scholar
• Morgan NG, Chan SL. Imidazoline binding sites in the endocrine pancreas: can they fulfil their potential as targets for the development of new insulin secretagogues?Curr Pharm Des 2001; 7:1413–1431.
   PubMed Web of Science ®Google Scholar
• Wang WZ, Yuan WJ, Ren AJ, Pan YX, Tang CS, Su DF. Role of I1-imidazoline receptors within the caudal ventrolateral medulla in cardiovascular responses to clonidine in rats. J Cardiovasc Pharmacol 2003; 42:1–9.
   PubMed Web of Science ®Google Scholar
• Head GA, Burke SL. I1 imidazoline receptors in cardiovascular regulation: the place of rilmenidine. Am J Hypertens 2000; 13: 89S–98S.
   Google Scholar
• Kim YH, Nam TS, Ahn DS, Chung S. Modulation of N-type Ca(2)(+) currents by moxonidine via imidazoline I(1) receptor activation in rat superior cervical ganglion neurons. Biochem Biophys Res Commun 2011; 409:645–650.
   PubMed Web of Science ®Google Scholar
• Yoro Sy G, Urosevic D, Fellmann L, Greney H, Bousquet P, Feldman J. G-protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidazoline receptor selective ligands. J Hypertens 2008; 26:1025–1032.
   PubMed Web of Science ®Google Scholar
• Harraz OF, El-Gowelli HM, Mohy El-Din MM, Ghazal AR, El-Mas MM. Adenosinergic modulation of the imidazoline I(1)- receptor-dependent hypotensive effect of ethanol in acute renal failure. Food Chem Toxicol 2012; 50:2622–2628.
   PubMed Web of Science ®Google Scholar
• Greney H, Ronde P, Magnier C, Maranca F, Rascente C, Quaglia W, et al. Coupling of I(1) imidazoline receptors to the cAMP pathway: studies with a highly selective ligand, benazoline. Mol Pharmacol 2000; 57:1142–1151.
   PubMed Web of Science ®Google Scholar
• Musgrave IF, Hughes R. Novel targets and techniques in imidazoline receptor research. Ann N Y Acad Sci 1999; 881:217–228.
   PubMedGoogle Scholar
• Ernsberger P. The I1-imidazoline receptor and its cellular signaling pathways. Ann N Y Acad Sci 1999; 881:35–53.
   PubMed Web of Science ®Google Scholar
• Piletz J, Ivanov T, Sharp J. Imidazoline receptor antiseraselected (IRAS) cDNA: cloning and characterization. DNA Cell Biol 2000; 19:319–329.
   PubMed Web of Science ®Google Scholar
• Zhu H, Hayes J, Chen M, Baldwin J, Piletz JE. Relationship between platelet imidazoline receptor-binding peptides and candidate imidazoline-1 receptor, IRAS. Ann N Y Acad Sci 2003; 1009:439–446.
   PubMed Web of Science ®Google Scholar
• Sano H, Liu S, Lane W. Insulin receptor substrate 4 associates with the protein IRAS. J Biol Chem 2002; 277:19439–19447.
   PubMed Web of Science ®Google Scholar
• Sun Z, Chung CH, Ernsberger P. Identification of IRAS/Nischarin as an I1-imidazoline receptor in PC12 rat pheochromocytoma cells. J Neurochem 2007; 101:99–108.
   PubMed Web of Science ®Google Scholar
• Alahari S, Lee J, Juliano R. Nischarin, a novel protein that interacts with the integrin alpha5 subunit and inhibits cell migration. J Cell Biol 2000; 151:1141–1154.
   PubMed Web of Science ®Google Scholar
• Dupuy L, Urosevic D, Greney H, Quaglia W, Pigini M, Brasili L, et al. I1 imidazoline receptor-mediated effects on apoptotic processes in PC12 cells. Cell Death Differ 2004; 11:1049–1052.
   PubMed Web of Science ®Google Scholar
• Dontenwill M, Pascal G, Piletz J. IRAS, the human homologue of Nischarin, prolongs survival of transfected PC12 cells. Cell Death Differ 2003; 10:933–935.
   PubMed Web of Science ®Google Scholar
• Musgrave IF, Dehle FC, Piletz J. Assembly of PRR-containing receptors on scaffolds: a model for imidazoline I(1)-receptor action. Ann N Y Acad Sci 2003; 1009:413–418.
   PubMed Web of Science ®Google Scholar
• Ernsberger P, Friedman J, Koletsky R. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J Hypertens Suppl 1997; 15:S9–S23.
   Google Scholar
• Ernsberger P, Damon T, Graff L, Schafer S, Christen M. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. J Pharmacol Exp Ther 1993; 264:172–182.
   PubMed Web of Science ®Google Scholar
• Ernsberger P. Pharmacology of moxonidine: an I1-imidazoline receptor agonist. J Cardiovasc Pharmacol 2000; 35:S27–S41.
   PubMed Web of Science ®Google Scholar
• Schann S, Greney H, Gasparik V, Dontenwill M, Rascente C, Lacroix G, et al. Methylation of imidazoline related compounds leads to loss of alpha(2)-adrenoceptor affinity. Synthesis and biological evaluation of selective I(1) imidazoline receptor ligands. Bioorg Med Chem 2012; 20:4710–4715.
   PubMed Web of Science ®Google Scholar
• Szabo B, Bock C, Nordheim U, Niederhoffer N. Mechanism of the sympatho-inhibition produced by the clonidine-like drugs rilmenidine and moxonidine. Ann N Y Acad Sci 1999; 881: 253–264.
   PubMed Web of Science ®Google Scholar
• Raasch W, Jungbluth B, Schafer U, Hauser W, Dominiak P. Norepinephrine release is reduced by I(1)-receptors in addition to alpha(2)-adrenoceptors. Ann N Y Acad Sci 2003; 1009:270–273.
   PubMed Web of Science ®Google Scholar
• Schafer U, Burgdorf C, Engelhardt A, Raasch W, Kurz T, Richardt G. Moxonidine displays a presynaptic alpha-2-adrenoceptor-dependent synergistic sympathoinhibitory action at imidazoline-1 receptors. Ann N Y Acad Sci 2003; 1009:265–269.
   PubMed Web of Science ®Google Scholar
• Sy GY, Bousquet P, Feldman J. Opposite to alpha2-adrenergic agonists, an imidazoline I1 selective compound does not influence reflex bradycardia in rabbits. Auton Neurosci 2006; 128:19–24.
   PubMed Web of Science ®Google Scholar
• Bousquet P, Greney H, Bruban V, Schann S, Ehrhardt JD, Monassier L, Feldman J. I(1) imidazoline receptors involved in cardiovascular regulation: where are we and where are we going?Ann N Y Acad Sci 2003; 1009:228–233.
   PubMed Web of Science ®Google Scholar
• Piletz J, Baker R, Halaris A. Platelet imidazoline receptors as state marker of depressive symptomatology. J Psychiatr Res 2008; 42:41–49.
   PubMed Web of Science ®Google Scholar
• Halaris A, Zhu H, Ali J, Nasrallah A, Lindsay De Vane C, Piletz JE. Down-regulation of platelet imidazoline-1-binding sites after bupropion treatment. Int J Neuropsychopharmacol 2002; 5:37–46.
   PubMed Web of Science ®Google Scholar
• Halaris A, Piletz JE. Relevance of imidazoline receptors and agmatine to psychiatry: a decade of progress. Ann N Y Acad Sci 2003; 1009:1–20.
   PubMed Web of Science ®Google Scholar
• Yokota S, Hikasa Y, Mizushima H. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on rabbit platelet aggregation. Pharmacology 2013; 91:135–144.
   PubMed Web of Science ®Google Scholar
• Halaris A, Piletz JE. Imidazoline receptors: possible involvement in the pathophysiology and treatment of depression. Hum Psychopharmacol 2001; 16:65–69.
   PubMed Web of Science ®Google Scholar
• Ogidigben MJ, Potter DE. Pharmacological evidence of a role for prejunctional imidazoline (I(1)) receptors in ocular function. Curr Eye Res 2002; 25:267–270.
   PubMed Web of Science ®Google Scholar
• Hong S, Kim C, Lee W, Shim J, Yeom H, Seong G. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model. Exp Eye Res 2010; 90:97–103.
   PubMed Web of Science ®Google Scholar
• Chao H, Osbourne N. Topically applied clonidine protects the rat retina from ischaemia/reperfusion by stimulating alpha(2)-adrenoceptors and not by an action on imidazoline receptors. Brain Res 2001; 904:126–136.
   PubMed Web of Science ®Google Scholar
• Kimura A, Tyacke RJ, Robinson JJ, Husbands SM, Minchin MC, Nutt DJ, Hudson AL. Identification of an imidazoline binding protein: creatine kinase and an imidazoline-2 binding site. Brain Res 2009; 1279:21–28.
   PubMed Web of Science ®Google Scholar
• Remaury A, Raddatz R, Orderner C, Savic S, Shih JC, Chen K, et al. Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase- deficient mouse models. Mol Pharmacol 2000; 58:1085–1090.
   PubMed Web of Science ®Google Scholar
• Zhu H, Piletz JE. Association between I(2) binding sites and monoamine oxidase-B activity in platelets. Ann N Y Acad Sci 2003; 1009:347–352.
   PubMed Web of Science ®Google Scholar
• McDonald GR, Olivieri A, Ramsay RR, Holt A. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B. Pharmacol Res2010; 62:475–488.
   Google Scholar
• Tesson F, Prip-Buus C, Limoine A. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane. J Biol Chem 1991; 266:155–160.
   Google Scholar
• Garcia-Sevilla JA, Miralles A, Sastre M. I2-imidazoline receptors in the healthy and pathologic human brain. Ann N Y Acad Sci 1995; 763:178–193.
   PubMedGoogle Scholar
• Sastre M, Escribe P, Reis D, Garcia-Sainz JA. Decreased number and immunoreactivity of I-2 imidazoline receptors in the frontal cortex of suicide victims. Ann N Y Acad Sci 1995; 763:520–522.
   PubMedGoogle Scholar
• Bhalla S, Ali I, Lee H, Andurkar SV, Gulati A. Potentiation of oxycodone antinociception in mice by agmatine and BMS182874 via an imidazoline I2 receptor-mediated mechanism. Pharmacol Biochem Behav 2013; 103:550–560.
   PubMed Web of Science ®Google Scholar
• Bhalla S, Andurkar SV, Gulati A. Involvement of alpha(2) - adrenoceptors, imidazoline, and endothelin-A receptors in the effect of agmatine on morphine and oxycodone-induced hypothermia in mice. Fundam Clin Pharmacol 2013; 27:498–509.
   PubMed Web of Science ®Google Scholar
• Bhalla S, Andurkar SV, Gulati A. Study of adrenergic, imidazoline, and endothelin receptors in clonidine-, morphine-, and oxycodone-induced changes in rat body temperature. Pharmacology 2011; 87:169–179.
   PubMed Web of Science ®Google Scholar
• Bhalla S, Rapolaviciute V, Gulati A. Determination of alpha(2)- adrenoceptor and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by agmatine and BMS182874. Eur J Pharmacol 2011; 651:109–121.
   PubMed Web of Science ®Google Scholar
• Gulati A, Bhalla S, Matwyshyn G, Zhang Z, Andurkar SV. Determination of adrenergic and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by clonidine and BMS182874. Pharmacology 2009; 83:45–58.
   PubMed Web of Science ®Google Scholar
• Li JX, Zhang Y, Winter JC. Morphine-induced antinociception in the rat: supra-additive interactions with imidazoline I(2) receptor ligands. Eur J Pharmacol 2011; 669:59–65.
   PubMed Web of Science ®Google Scholar
• Li JX, Zhang Y. Imidazoline I2 receptors: target for new analgesics?Eur J Pharmacol 2011; 658:49–56.
   PubMed Web of Science ®Google Scholar
• Georges F, Aston-Jones G. Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors. Neuropsychopharmacology 2003; 28:1140–1149.
   PubMed Web of Science ®Google Scholar
• Georges F, Caille S, Vouillac C, Le Moine C, Stinus L. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats. Eur J Neurosci 2005; 22:1812–1816.
   PubMed Web of Science ®Google Scholar
• Su CH, Liu IM, Chung HH, Cheng JT. Activation of I2-imidazoline receptors by agmatine improved insulin sensitivity through two mechanisms in type-2 diabetic rats. Neurosci Lett 2009; 457:125–128.
   PubMed Web of Science ®Google Scholar
• Chen CT, Chen W, Chung HH, Cheng KC, Yeh CH, Cheng JT. Activation of imidazoline I-2B receptor by metformin to increase glucose uptake in skeletal muscle. Horm Metab Res 2011; 43: 708–713.
   PubMed Web of Science ®Google Scholar
• Lee JP, Chen W, Wu HT, Lin KC, Cheng JT. Metformin can activate imidazoline I-2 receptors to lower plasma glucose in type 1-like diabetic rats. Horm Met Res 2011; 43:26–30.
   PubMed Web of Science ®Google Scholar
• Derosa G, Cicero AF, D’Angelo A, Fogari E, Salvadeo S, Gravina A, et al. Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial. Clin Ther 2007; 29:602–610.
   PubMed Web of Science ®Google Scholar
• Sanjuliani AF, de Abreu VG, Francischetti EA. Selective imidazoline agonist moxonidine in obese hypertensive patients. Int J Clin Pract 2006; 60:621–629.
   PubMed Web of Science ®Google Scholar
• Fenton C, Keating GM, Lyseng-Williamson KA. Moxonidine: a review of its use in essential hypertension. Drugs 2006; 66: 477–496.
   PubMed Web of Science ®Google Scholar
• Aguilar-Bryan I, Clement J, Gonzalez G, Kunjil-War K, Babenko A, Bryan J. Toward understanding the assembly and structure of KATP channels. Physiol Rev 1998; 78:227–245.
   PubMed Web of Science ®Google Scholar
• Kawahito S, Kawano T, Kitahata H, Oto J, Takahashi A, Takaishi K, et al. Molecular mechanisms of the inhibitory effects of clonidine on vascular adenosine triphosphate–sensitive potassium channels. Anesth Analg 2011; 113:1374–1380.
   PubMed Web of Science ®Google Scholar
• Proks P, Ashcroft F. Phentolamine block of KATP channels is mediated by Kir6.2. Proc Natl Acad Sci U S A 1997; 94:11716–11720.
   PubMed Web of Science ®Google Scholar
• Mukai E, Ishida H, Horie M, Noma A, Seino Y, Takano M. The antiarrythmic agent cibenzoline inhibits KATP channels by binding to Kir6.2. Biochem Biophys Res Commun 1998; 251: 477–481.
   PubMed Web of Science ®Google Scholar
• Sharoyko VV, Zaitseva, II, Leibiger B, Efendic S, Berggren PO, Zaitsev SV. Arachidonic acid signaling is involved in the mechanism of imidazoline-induced KATP channel-independent stimulation of insulin secretion. Cell Mol Life Sci 2007; 64:2985–2993.
   PubMed Web of Science ®Google Scholar
• Efanov A, Zaitsev SV, Mest H, Raap A, Appelskog IB, Larsson O, et al. The novel imidazoline compound BL11282 potentiates glucose-induced insulin secretion in pancreatic beta-cells in the absence of modulation of K(ATP) channel activity. Diabetes 2001; 50:797–802.
   PubMed Web of Science ®Google Scholar
• Morgan NG, Cooper E, Squires PE, Hills CE, Parker C, Hudson A. Comparative effects of efaroxan and beta-carbolines on the secretory activity of rodent and human beta cells. Ann N Y Acad Sci 2003; 1009:167–174.
   PubMed Web of Science ®Google Scholar
• Nikolic K, Agbaba D. Imidazoline antihypertensive drugs: selective i(1)-imidazoline receptors activation. Cardiovasc Ther 2012; 30:209–216.
   PubMed Web of Science ®Google Scholar
• Tesfai J, Crane L, Baziard-Mouysset G, Kennedy W, Edwards LP. Novel I1-imidazoline S43126 enhance insulin action in PC12 cells. Pharmacol Rep 2011; 63:1442–1449.
   PubMed Web of Science ®Google Scholar
• Atlas D, Burstein Y. Isolation of an endogenous clonidine-displacing substance from rat brain. FEBS Lett 1984; 170:387–390.
   PubMed Web of Science ®Google Scholar
• Parini A, Coupry I, Graham RM, Uzielli I, Atlas D, Lanier SM. Characterization of an imidazoline/guanidinium receptive site distinct from the alpha 2-adrenergic receptor. J Biol Chem 1989; 264:11874–11878.
   PubMed Web of Science ®Google Scholar
• Meeley M, Hensley M, Ernsberger P, Felsen D, Reis D. Evidence for a bioactive clonidine-displacing substance in peripheral tissues and serum. Biochem Pharmacol 1992; 44:733–740.
   PubMed Web of Science ®Google Scholar
• Goldberg-Stern H, Atlas D, Schwartz L, Achiron A, Ziv I, Djaldetti R, et al. Detection and measurement of an endogenous clonidine-displacing substance in human cerebrospinal fluid. Brain Res 1993; 601:325–328.
   PubMed Web of Science ®Google Scholar
• Mukaddam-Daher S, Gutkowska J. Imidazoline receptors in the heart: a novel target and a novel mechanism of action that involves atrial natriuretic peptides. Braz J Med Biol Res 2004; 37:1239–1245.
   PubMed Web of Science ®Google Scholar
• Molderings GJ, Haenisch B. Agmatine (decarboxylated L-arginine): physiological role and therapeutic potential. Pharmacol Ther 2012; 133:351–365.
   PubMed Web of Science ®Google Scholar
• Parker CA, Anderson NJ, Robinson ES, Price R, Tyacke RJ, Husbands SM, et al. Harmane and harmalan are bioactive components of classical clonidine-displacing substance. Biochemistry 2004; 43:16385–16392.
   PubMed Web of Science ®Google Scholar
• Husbands S, Glennon RA, Gorgerat S, Gough R, Tyacke R, Crosby J, et al. Beta-carboline binding to imidazoline receptors. Drug Alcohol Depend 2001; 64:203–208.
   PubMed Web of Science ®Google Scholar
• Prell GD, Martinelli GP, Holstein GR, Matulić-Adamić J, Watanabe KA, Chan SL, et al. Imidazoleacetic acid-ribotide: an endogenous ligand that stimulates imidazol(in)e receptors. Proc Natl Acad Sci USA 2004; 101:13677–13682.
   PubMed Web of Science ®Google Scholar
• Madsen C, Jensen AA, Liljefors T, Kristiansen U, Nielsen B, Hansen CP, et al. 5-Substituted imidazole-4-acetic acid analogues: synthesis, modeling, and pharmacological characterization of a series of novel gamma-aminobutyric acid(C) receptor agonists. J Med Chem 2007; 50:147–161.
   Google Scholar
• Friedrich VL Jr, Martinelli GP, Prell G, Holstein GR. Distribution and cellular localization of imidazoleacetic acid-ribotide, an endogenous ligand at imidazol(in)e and adrenergic receptors, in rat brain. J Chem Neuroanat 2007; 33:53–64.
   PubMed Web of Science ®Google Scholar
• Martinelli GP, Friedrich VL Jr, Prell G, Holstein GR. Vestibular neurons in the rat contain imidazoleacetic acid-ribotide, a putative neurotransmitter involved in blood pressure regulation. J Comp Neurol 2007; 201:568–581.
   Google Scholar
• Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC. 2011 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol (Phila) 2012; 50:911–1164.
   PubMed Web of Science ®Google Scholar
• Lowenstein J. Drugs five years later: clonidine. Ann Intern Med 1980; 92:74–77.
   PubMed Web of Science ®Google Scholar
• Artman M, Boerth RC. Clonidine poisoning. A complex problem. Am J Dis Child 1983; 137:171–174.
   PubMedGoogle Scholar
• Wiley JF II, Wiley CC, Torrey SB, Henretig FM. Clonidine poisoning in young children. J Pediatr 1990; 116:654–658.
   PubMed Web of Science ®Google Scholar
• Bamshad MJ, Wasserman GS. Pediatric clonidine intoxications. Vet Hum Toxicol 1990; 32:220–223.
   PubMedGoogle Scholar
• Nichols MH, King WD, James LP. Clonidine poisoning in Jefferson County, Alabama. Ann Emerg Med 1997; 29:511–517.
   PubMed Web of Science ®Google Scholar
• Klein-Schwartz W. Trends and toxic effects from pediatric clonidine exposures. Arch Pediatr Adolesc Med 2002; 156:392–396.
   PubMed Web of Science ®Google Scholar
• Yoon E, Cohn L, Rocchini A, Kershaw D, Clark S. Clonidine utilization trends for Medicaid children. Clin Pediatr (Phila) 2012; 51:950–955.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Klein-Schwartz W, Colvin JM, Villalobos D, Johnson PB, Anderson DL. Toxic clonidine ingestion in children. J Pediatr 2005; 146:263–266.
   PubMed Web of Science ®Google Scholar
• Rapko D, Rastegar D. Intentional clonidine patch ingestion by 3 adults in a detoxification unit. Arch Internal Med 2003; 163:367–368.
   PubMed Web of Science ®Google Scholar
• Killian C, Roberge R, Krenzelok E, Stonage C.“Cloniderm” toxicity: another manifestation of clonidine overdose. Pediatr Emerg Care 1997; 13:340–341.
   PubMed Web of Science ®Google Scholar
• Raber J, Shinar C, Finkelstein S. Clonidine patch ingestion in an adult. Ann Pharmacother 1993; 27:719–722.
   PubMed Web of Science ®Google Scholar
• Horowitz R, Mazor SS, Aks SE, Leikin JB. Accidental clonidine patch ingestion in a child. Am J Ther 2005; 12:272–274.
   PubMedGoogle Scholar
• Van Dyke MW, Bonace AL, Ellenhorn MJ. Guanfacine overdose in a pediatric patient. Vet Human Toxicol 1990; 32:46–47.
   PubMedGoogle Scholar
• Minns AB, Clark RF, Schneir A. Guanfacine overdose resulting in initial hypertension and subsequent delayed, persistent orthostatic hypotension. Clin Toxicol (Phila) 2010; 48:146–148.
   PubMed Web of Science ®Google Scholar
• Takamatsu I, Iwase A, Ozaki M, Kazama T, Wada K, Sekiguchi M. Dexmedetomidine reduces long-term potentiation in mouse hippocampus. Anesthesiology 2008; 108:94–102.
   PubMed Web of Science ®Google Scholar
• Virtanen R, Savola JM, Saano V, Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol 1988; 150:9–14.
   PubMed Web of Science ®Google Scholar
• Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93:382–394.
   PubMed Web of Science ®Google Scholar
• Jorden VS, Pousman RM, Sanford MM, Thorborg PA, Hutchens MP. Dexmedetomidine overdose in the perioperative setting. Ann Pharmacother 2004; 38:803–807.
   PubMed Web of Science ®Google Scholar
• Rosen DA, Daume JT. Short duration large dose dexmedetomidine in a pediatric patient during procedural sedation. Anesth Analg 2006; 103:68–9, table of contents.
   PubMed Web of Science ®Google Scholar
• Max BA, Mason KP. Extended infusion of dexmedetomidine to an infant at sixty times the intended rate. Int J Pediatr 2010;2010, pii: 825079.
   PubMedGoogle Scholar
• Bernard PA, Makin CE, Werner HA. Hypoglycemia associated with dexmedetomidine overdose in a child?J Clin Anesth 2009; 21:50–53.
   PubMed Web of Science ®Google Scholar
• Head GA. Central imidazoline- and alpha 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents. Ann N Y Acad Sci 1999; 881:279–286.
   PubMed Web of Science ®Google Scholar
• Turcani M. Biphasic dose-dependent modulation of cardiac parasympathetic activity by moxonidine, an imidazoline I1-receptor agonist. J Cardiovasc Pharmacol 2008; 52:524–535.
   PubMed Web of Science ®Google Scholar
• Kino Y, Tanabe M, Honda M, Ono H. Involvement of supraspinal imidazoline receptors and descending monoaminergic pathways in tizanidine-induced inhibition of rat spinal reflexes. J Pharmacol Sci 2005; 99:52–60.
   PubMed Web of Science ®Google Scholar
• Dahlstrom M, LIndgren F, Berntsson K, Sjögren M, Mårtensson LG, Jonsson PR, Elwing H. Evidence for different pharmacological targets for imidazoline compounds inhibiting settlement of the barnacle Balanus improvisus. J Exp Zool A Comp Exp Biol 2005; 303:551–562.
   PubMedGoogle Scholar
• Ruffolo RR Jr, Waddell JE. Receptor interactions of imidazolines: alpha-adrenoceptors of rat and rabbit aortae differentiated by relative potencies, affinities and efficacies of imidazoline agonists. Br J Pharmacol 1982; 77:169–176.
   PubMed Web of Science ®Google Scholar
• Salazar-Bookaman M, Miller D, Patil P. Antagonism by imidazoline-type drugs of muscarinic and other receptors in the guinea-pig ileum. Auton Autocoid Pharmacol 2006; 26:267–273.
   PubMedGoogle Scholar
• Daggy A, Kaplan R, Roberge R, Akhtar J. Pediatric Visine (tetrahydrozoline) ingestion: case report and review of imidazoline toxicity. Vet Hum Toxicol 2003; 45:210–212.
   PubMedGoogle Scholar
• Eddy O, Howell JM. Are one or two dangerous?Clonidine and topical imidazolines exposure in toddlers. J Emerg Med 2003; 25:297–302.
   Google Scholar
• Carr ME, Engebretsen KM, Ho B, Anderson CP. Tetrahydrozoline (Visine(R)) concentrations in serum and urine during therapeutic ocular dosing: a necessary first step in determining an overdose. Clin Toxicol (Phila) 2011; 49:810–814.
   PubMed Web of Science ®Google Scholar
• Lowry JA, Garg U. Serum concentrations in three children with unintentional tetrahydrozoline overdose. Clin Toxicol (Phila) 2011; 49:434–435.
   PubMed Web of Science ®Google Scholar
• Stillwell ME, Saady JJ. Use of tetrahydrozoline for chemical submission. Forensic Sci Int 2012; 221:e12–e16.
   Google Scholar
• Spiller HA, Siewert DJ. Drug-facilitated sexual assault using tetrahydrozoline. J Forensic Sci 2012; 57:835–838.
   PubMed Web of Science ®Google Scholar
• Rehbinder D, Deckers W. Studies on the pharmacokinetics and on metabolism of 2 (2,6-dichlorphenylamino)-2-imidazoline- hydrochloride. Arzneimittelforschung 1969; 19:169–176.
   PubMed Web of Science ®Google Scholar
• Bucaretchi F, Dragosavac S, Vieira RJ. Acute exposure to imidazoline derivatives in children. J Pediatr (Rio J) 2003; 79: 519–524.
   PubMedGoogle Scholar
• Mindlin RL. Accidental poisoning from tetrahydrozoline eye-drops (letter). N Eng J Med 1966; 275:112.
   Google Scholar
• Klein-Schwartz W, Gorman R, Oderda GM, Baig A. Central nervous system depression from ingestion of nonprescription eyedrops. Am J Emerg Med 1984; 2:217–218.
   PubMed Web of Science ®Google Scholar
• Jensen P, Edgren B, Hall L, Ring JC. Hemodynamic effects following ingestion of an imidazoline-containing product. Pediatr Emerg Care 1989; 5:110–112.
   PubMedGoogle Scholar
• Higgins GL III, Campbell B, Wallace K, Talbot S. Pediatric poisoning from over-the-counter imidazoline-containing products. Ann Emerg Med 1991; 20:655–658.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Bosse GM, Adamson LA. Retrospective review of Tizanidine (Zanaflex) overdose. J Toxicol Clin Toxicol 2004; 42:593–596.
   PubMed Web of Science ®Google Scholar
• Rangan C, Everson G, Cantrell FL. Central alpha-2 adrenergic eye drops: case series of 3 pediatric systemic poisonings. Pediatr Emerg Care 2008; 24:167–169.
   PubMed Web of Science ®Google Scholar
• Osterhoudt KC, Henretig FM. Sinoatrial node arrest following tetrahydrozoline ingestion. J Emerg Med 2004; 27:313–314.
   PubMed Web of Science ®Google Scholar
• Spiller H, Griffith J. Prolonged cardiovascular effects after unintentional ingestion of tetrahydrozoline. Clin Toxicol (Phila) 2008; 46:171–172.
   PubMed Web of Science ®Google Scholar
• Lev R, Clark RF. Visine overdose: case report of an adult with hemodynamic compromise. J Emerg Med 1995; 13:649–652.
   PubMedGoogle Scholar
• Fukushima H, Norimoto K, Seki T, Nishiguchi T, Nakamura T, Konobu T, et al. Acute pulmonary edema associated with naphazoline ingestion. Clin Toxicol (Phila) 2008; 46:254–256.
   PubMed Web of Science ®Google Scholar
• Mpanduji D, Bittegeko S, Batamuzi E, Mgasa M, Shami C. Comparison of the effects of atipamezole and tolazoline on analgesia, cardiopulmonary and rectal temperature changes induced by lumbosacral epidural injection of medetomidine in goats. Small Rumin Res 2001; 40:117–122.
   PubMed Web of Science ®Google Scholar
• Hikasa Y, Abe M, Satoh T, Hisashi Y, Ogasawara S, Matsuda H. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation. Pharmacology 1999; 58:171–182.
   PubMed Web of Science ®Google Scholar
• Miller B, Muller L, Doherty T, Osborn D, Miller K, Warren R. Effectiveness of antagonists for tiletamine-zolazepam/xylazine immobilization in female white-tailed deer. J Wildl Dis 2004; 40:533–537.
   PubMed Web of Science ®Google Scholar
• Mendoza J, Medalie M. Clonidine poisoning with marked hypotension in a 2 1/2-year-old child. Clin Pediatr (Phila) 1979; 18:1123–1127.
   Google Scholar
• Schieber R, Kaufman N. Use of tolazoline in massive clonidine poisoning. Am J Dis Child 1981; 135:77–78.
   PubMedGoogle Scholar
• Shannon M, Neuman M. Yohimbine. Pediatr Emerg Care 2000; 16:49–50.
   PubMed Web of Science ®Google Scholar
• Moreira T, Takakura A, Menani JV, Columbari E. Involvement of central α1- and α2-adrenoceptors on cardiovascular responses to moxonidine. Eur J Pharmacol 2007; 563:164–171.
   PubMed Web of Science ®Google Scholar
• Roberge R, Mcguire S, Krenzelok E. Yohimbine as an antidote for clonidine ingestion. Am J Emerg Med 1996; 14:678–680.
   PubMed Web of Science ®Google Scholar
• Lui N, Bonnet F, Delaunay L. Partial reversal of the effects of extradural clonidine by oral yohimbine in postoperative patients. Br J Anaesth 1993; 70:515–518.
   PubMed Web of Science ®Google Scholar
• Sjoholm B, Voutilainen R, Louomala K, Savola JM, Scheinin M. Characterization of [H3] atipamezole as a radioligand for alpha-2 adrenoceptors. Eur J Clin Pharmacol 1992; 215:109–117.
   Web of Science ®Google Scholar
• Sjoholm B, Savola JM, Scheinin M. Nonadrenergic binding of [H3] atipamezole in rat lung. Ann N Y Acad Sci 1995; 763:66–77.
   PubMedGoogle Scholar
• Romer L, Wurster S, Savola JM, Raasmaja A. Identification and characterization of the imidazoline I2b-binding sites in the hamster brown adipose tissue as a study model for imidazoline receptors. Arch Physiol Biochem 2003; 111:159–166.
   PubMedGoogle Scholar
• Scheinin H, Aantaa R, Anttila M, Hakola P, Helminen A, Karhuvaara S. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Anesthesiology 1998; 89:574–584.
   PubMed Web of Science ®Google Scholar
• Penttila J, Kaila T, Helminen A, Anttila M, Karhuvaara S, Huhtala S, Scheinin H. Effects of atipamezole–a selective alpha-adrenoceptor antagonist–on cardiac parasympathetic regulation in human subjects. Auton Autocoid Pharmacol 2004; 24:69–75.
   PubMedGoogle Scholar
• Tsze DS, Dayan PS. Treatment of guanfacine toxicity with naloxone. Pediatric Emerg Care 2012; 28:1060–1061.
   PubMed Web of Science ®Google Scholar
• Ahmad SA, Scolnik D, Snehal V, Glatstein M. Use of naloxone for clonidine intoxication in the pediatric age group: Case report and review of the literature. Am J Ther 2013. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Holmes JF, Berman DA. Use of naloxone to reverse symptomatic tetrahydrozoline overdose in a child. Pediatr Emerg Care 1999; 15:193–194.
   PubMed Web of Science ®Google Scholar
• Katar S, Taskesen M, Okur N. Naloxone use in a newborn with apnea due to tetrahydrozoline intoxication. Pediatr Int 2010; 52:488–489.
   PubMed Web of Science ®Google Scholar
• Banner W Jr, Lund ME, Clawson L. Failure of naloxone to reverse clonidine toxic effect. Am J Dis Child 1983; 137: 1170–1171.
   PubMedGoogle Scholar
• Maggi JC, Iskra MK, Nussbaum E. Severe clonidine overdose in children requiring critical care. Clin Pdiatr 1986; 25:453–455.
   PubMed Web of Science ®Google Scholar
• Spiller HA, Rogers J, Sawyer TS. Drug facilitated sexual assault using an over-the-counter ocular solution containing tetrahydrozoline (Visine). Leg Med (Tokyo) 2007; 9:192–195.
   PubMedGoogle Scholar
• Lusthof KJ, Lameijer W, Zweipfenning PG. Use of clonidine for chemical submission. J Toxicol Clin Toxicol 2000; 38: 329–332.
   PubMed Web of Science ®Google Scholar